Ropes & Gray advised Xeris Biopharma Holdings on the transaction. Xeris Biopharma Holdings, Inc. (Nasdaq:XERS) (Xeris), a biopharmaceutical company, announced that it has entered into an exclusive worldwide...
You must be a Standard 1 Year member to access this content.
Cleary Gottlieb Steen & Hamilton represented Synopsys, Sidley Austin acted as lead legal advisor to Clearlake and Francisco Partners, Simpson Thacher & Bartlett also advised Francisco...
You must be a Standard 1 Year member to access this content.
Bracewell represented the underwriters in the offering. DTE Energy Company (NYSE: DTE) (DTE Energy) announced its public offering of $850 million of 2024 Series D 5.85% Senior...
You must be a Standard 1 Year member to access this content.
Cleary Gottlieb Steen & Hamilton represented the representatives of the underwriters in the offering. Southern California Edison Co. (SCE) announced an offering of $750 million aggregate principal...
You must be a Standard 1 Year member to access this content.
Fenwick & West represented Pharmakon Advisors in the transaction. Novocure (NASDAQ: NVCR) announced today that it has entered into a new five-year up to $400 million...
You must be a Standard 1 Year member to access this content.
O’Melveny advised Zanskar Geothermal & Minerals on the deal. Zanskar Geothermal & Minerals, the leading geothermal exploration company, announced its US$30 million Series B funding round....
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Aledade on the transaction. Aledade, the nation’s largest and most successful network of physician-led value-based care, announced that it has...
You must be a Standard 1 Year member to access this content.
Wachtell, Lipton, Rosen & Katz served as legal advisor to National MI. National MI (Nasdaq: NMIH), a mortgage insurance company, announced that it had priced its...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Transcarent on the transaction. Health tech company, Transcarent announced?raising $126 million in Series D funding round led by General Catalyst and...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Enlaza on IP matters related to the transaction. Enlaza Therapeutics (Enlaza), the first covalent biologic platform company, announced it closed...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Novo Holdings on the transaction. Reunion Neuroscience Inc., a clinical-stage biopharmaceutical company, announced the close of a $103 million Series A...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr represented Alethea in the transaction. Alethea, a leading technology company in disinformation detection and mitigation, announced it has raised $20 million in Series...
You must be a Standard 1 Year member to access this content.
